triazoles has been researched along with Shock, Cardiogenic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouadma, L; Da Silva, D; Massias, L; Nataf, P; Papy, E; Ruiz, S; Wolff, M | 1 |
| Araújo, CV; Barbosa-Filho, JM; Cordeiro, RS; Tibiriçá, E | 1 |
2 other study(ies) available for triazoles and Shock, Cardiogenic
| Article | Year |
|---|---|
Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation.
Topics: Adult; Antifungal Agents; Caspofungin; Echinocandins; Extracorporeal Membrane Oxygenation; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Myocarditis; Pyrimidines; Shock, Cardiogenic; Triazoles; Voriconazole | 2009 |
Protective effects of yangambin on cardiovascular hyporeactivity to catecholamines in rats with endotoxin-induced shock.
Topics: Animals; Azepines; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Drug Interactions; Furans; Heart Rate; Lignans; Lipopolysaccharides; Male; Norepinephrine; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock, Cardiogenic; Shock, Septic; Triazoles; Vasoconstrictor Agents | 2001 |